Cargando…
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649266/ https://www.ncbi.nlm.nih.gov/pubmed/36382051 http://dx.doi.org/10.1097/HS9.0000000000000800 |
| _version_ | 1784827761911660544 |
|---|---|
| author | Sgherza, Nicola Di Gennaro, Daniela Curci, Paola Rizzi, Rita Roccotelli, Daniela Croce, Maria Avantaggiato, Martina Ruga, Loredana Strafella, Vanda Vitucci, Angelantonio Palma, Antonio Russo Rossi, Antonella V. Troiano, Teresa Larocca, Angela M. V. Chironna, Maria Tafuri, Silvio Albano, Francesco Musto, Pellegrino |
| author_facet | Sgherza, Nicola Di Gennaro, Daniela Curci, Paola Rizzi, Rita Roccotelli, Daniela Croce, Maria Avantaggiato, Martina Ruga, Loredana Strafella, Vanda Vitucci, Angelantonio Palma, Antonio Russo Rossi, Antonella V. Troiano, Teresa Larocca, Angela M. V. Chironna, Maria Tafuri, Silvio Albano, Francesco Musto, Pellegrino |
| author_sort | Sgherza, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9649266 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96492662022-11-14 SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance Sgherza, Nicola Di Gennaro, Daniela Curci, Paola Rizzi, Rita Roccotelli, Daniela Croce, Maria Avantaggiato, Martina Ruga, Loredana Strafella, Vanda Vitucci, Angelantonio Palma, Antonio Russo Rossi, Antonella V. Troiano, Teresa Larocca, Angela M. V. Chironna, Maria Tafuri, Silvio Albano, Francesco Musto, Pellegrino Hemasphere Letter Lippincott Williams & Wilkins 2022-11-09 /pmc/articles/PMC9649266/ /pubmed/36382051 http://dx.doi.org/10.1097/HS9.0000000000000800 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Sgherza, Nicola Di Gennaro, Daniela Curci, Paola Rizzi, Rita Roccotelli, Daniela Croce, Maria Avantaggiato, Martina Ruga, Loredana Strafella, Vanda Vitucci, Angelantonio Palma, Antonio Russo Rossi, Antonella V. Troiano, Teresa Larocca, Angela M. V. Chironna, Maria Tafuri, Silvio Albano, Francesco Musto, Pellegrino SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title | SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title_full | SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title_fullStr | SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title_full_unstemmed | SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title_short | SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance |
| title_sort | sars-cov-2 infection incidence and outcome before and after full vaccination in patients with monoclonal gammopathy of undetermined significance |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649266/ https://www.ncbi.nlm.nih.gov/pubmed/36382051 http://dx.doi.org/10.1097/HS9.0000000000000800 |
| work_keys_str_mv | AT sgherzanicola sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT digennarodaniela sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT curcipaola sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT rizzirita sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT roccotellidaniela sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT crocemaria sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT avantaggiatomartina sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT rugaloredana sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT strafellavanda sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT vitucciangelantonio sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT palmaantonio sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT russorossiantonellav sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT troianoteresa sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT laroccaangelamv sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT chironnamaria sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT tafurisilvio sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT albanofrancesco sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance AT mustopellegrino sarscov2infectionincidenceandoutcomebeforeandafterfullvaccinationinpatientswithmonoclonalgammopathyofundeterminedsignificance |